BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vini R, Rajavelu A, Sreeharshan S. 27-Hydroxycholesterol, The Estrogen Receptor Modulator, Alters DNA Methylation in Breast Cancer. Front Endocrinol 2022;13:783823. [DOI: 10.3389/fendo.2022.783823] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Singh P, Paramanik V. Neuromodulating roles of estrogen and phytoestrogens in cognitive therapeutics through epigenetic modifications during aging. Front Aging Neurosci 2022;14:945076. [DOI: 10.3389/fnagi.2022.945076] [Reference Citation Analysis]
2 Abdalkareem Jasim S, Kzar HH, Haider Hamad M, Ahmad I, Al-gazally ME, Ziyadullaev S, Sivaraman R, Abed Jawad M, Thaeer Hammid A, Oudaha KH, Karampoor S, Mirzaei R. The emerging role of 27-hydroxycholesterol in cancer development and progression: An update. International Immunopharmacology 2022;110:109074. [DOI: 10.1016/j.intimp.2022.109074] [Reference Citation Analysis]
3 Holý P, Hlaváč V, Ostašov P, Brynychová V, Koževnikovová R, Trnková M, Kopečková K, Měšťáková S, Mrhalová M, Souček P. Germline and somatic genetic variability of oxysterol-related genes in breast cancer patients with early disease of the luminal subtype. Biochimie 2022:S0300-9084(22)00110-9. [PMID: 35525372 DOI: 10.1016/j.biochi.2022.04.015] [Reference Citation Analysis]